FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

21208511000001102: Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Oct 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
70879001000001115 Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
70879101000001119 Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Is a Linagliptin 2.5mg / Metformin 1g tablets true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Metformin hydrochloride true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Linagliptin false Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Is a Jentadueto true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has active ingredient Metformin true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) 56 tablet 8 x 7 tablets Has AMP True Jentadueto 2.5mg/1000mg tablets (Boehringer Ingelheim Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start